BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22888107)

  • 1. Chemometrics applications in biotechnology processes: predicting column integrity and impurity clearance during reuse of chromatography resin.
    Rathore AS; Mittal S; Lute S; Brorson K
    Biotechnol Prog; 2012; 28(5):1308-14. PubMed ID: 22888107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving affinity chromatography resin efficiency using semi-continuous chromatography.
    Mahajan E; George A; Wolk B
    J Chromatogr A; 2012 Mar; 1227():154-62. PubMed ID: 22265178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved process analytical technology for protein a chromatography using predictive principal component analysis tools.
    Hou Y; Jiang C; Shukla AA; Cramer SM
    Biotechnol Bioeng; 2011 Jan; 108(1):59-68. PubMed ID: 20672251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Process development in the Quality by Design paradigm: Modeling of Protein A chromatography resin fouling.
    Shekhawat LK; Pathak M; Sakar J; Rathore AS
    J Chromatogr A; 2018 Oct; 1570():56-66. PubMed ID: 30076007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a new protein A affinity membrane for the primary recovery of antibodies.
    Boi C; Dimartino S; Sarti GC
    Biotechnol Prog; 2008; 24(3):640-7. PubMed ID: 18473438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiproduct Resin Reuse for Clinical and Commercial Manufacturing-Methodology and Acceptance Criteria.
    Sharnez R; Doares S; Manning S; Mehta K; Mahajan E; To A; Daniels W; Glynn J; Dhamane S; Wen X; Wang Y; Gour P; Guenther C; Foley D; Hayes R; Mott A; Prabhu S; Tavalsky D; Hendershot M; Haas D; Hesslein A; Schuelke N; Tjandra H
    PDA J Pharm Sci Technol; 2018; 72(6):584-598. PubMed ID: 30030349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating multiproduct chromatography Protein A resin reuse for monoclonal antibodies in biopharmaceutical manufacturing.
    Ravi N; Huerta J; Ferreira G
    Biotechnol Prog; 2023; 39(3):e3333. PubMed ID: 36795072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated continuous biomanufacturing platform with ATF perfusion and one column chromatography operation for optimum resin utilization and productivity.
    Kamga MH; Cattaneo M; Yoon S
    Prep Biochem Biotechnol; 2018 May; 48(5):383-390. PubMed ID: 29509101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twin-column CaptureSMB: a novel cyclic process for protein A affinity chromatography.
    Angarita M; Müller-Späth T; Baur D; Lievrouw R; Lissens G; Morbidelli M
    J Chromatogr A; 2015 Apr; 1389():85-95. PubMed ID: 25748537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Online integrity monitoring in the protein A step of mAb production processes-increasing reliability and process robustness.
    Bork C; Holdridge S; Walter M; Fallon E; Pohlscheidt M
    Biotechnol Prog; 2014; 30(2):383-90. PubMed ID: 24376144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of overloaded cation exchange chromatography for monoclonal antibody purification.
    Liu HF; McCooey B; Duarte T; Myers DE; Hudson T; Amanullah A; van Reis R; Kelley BD
    J Chromatogr A; 2011 Sep; 1218(39):6943-52. PubMed ID: 21871630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A straightforward methodology for designing continuous monoclonal antibody capture multi-column chromatography processes.
    Gjoka X; Rogler K; Martino RA; Gantier R; Schofield M
    J Chromatogr A; 2015 Oct; 1416():38-46. PubMed ID: 26363944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of batch and continuous multi-column protein A capture processes by optimal design.
    Baur D; Angarita M; Müller-Späth T; Steinebach F; Morbidelli M
    Biotechnol J; 2016 Jul; 11(7):920-31. PubMed ID: 26992151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A safe, effective, and facility compatible cleaning in place procedure for affinity resin in large-scale monoclonal antibody purification.
    Wang L; Dembecki J; Jaffe NE; O'Mara BW; Cai H; Sparks CN; Zhang J; Laino SG; Russell RJ; Wang M
    J Chromatogr A; 2013 Sep; 1308():86-95. PubMed ID: 23953712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of new affinity chromatography resins for polyclonal, oligoclonal and monoclonal antibody pharmaceuticals.
    Ishihara T; Nakajima N; Kadoya T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2141-4. PubMed ID: 20591751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanistic study of Protein A chromatography resin lifetime.
    Jiang C; Liu J; Rubacha M; Shukla AA
    J Chromatogr A; 2009 Jul; 1216(31):5849-55. PubMed ID: 19539295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a novel affinity adsorbent for the capture and purification of recombinant factor VIII compounds.
    McCue JT; Selvitelli K; Walker J
    J Chromatogr A; 2009 Nov; 1216(45):7824-30. PubMed ID: 19800068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode.
    Shamashkin M; Godavarti R; Iskra T; Coffman J
    Biotechnol Bioeng; 2013 Oct; 110(10):2655-63. PubMed ID: 23633385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process.
    Chen J; Tetrault J; Ley A
    J Chromatogr A; 2008 Jan; 1177(2):272-81. PubMed ID: 17709111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximizing the functional lifetime of Protein A resins.
    Zhang J; Siva S; Caple R; Ghose S; Gronke R
    Biotechnol Prog; 2017 May; 33(3):708-715. PubMed ID: 28218470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.